192 - Evaluation Of Oral Vancomycin for Primary Clostridioides difficile Prophylaxis in Hematopoietic Stem Cell Transplant Recipient Patients

Co-Author(s)

• MS

  Marina Samuel, PharmD

  NYU Langone Health
  New York, New York, United States
• FC

  Frank Cirrone, PharmD, BCOP

  AstraZeneca
  New York, New York, United States
• RA

  Rachel Abramova, PharmD, BCOP

  NYU Langone Health
  New York, New York, United States

Presenting Author(s)

• 

  Yanina Dubrovskaya, PharmD, BCIDP, AAHIVP, FIDSA

  Assistant Director of Clinical Pharmacy Services - Infectious Diseases/Antimicrobial Stewardship
  NYU Langone Health
  New York, NY, United States

  Slides

Co-Author(s)

• JP

  John Papadopoulos, PharmD

  Director of Clinical Pharmacy Services
  NYU Langone Health
  New York, New York, United States
• 

  Sarah E. Hochman, MD

  Hospital Epidemiologist, Infectious Diseases Section Chief, Occupational Health Medical Director
  NYU Langone Health
  New York, NY, United States
• 

  Kassandra Marsh, PharmD, BCIDP (she/her/hers)

  Clinical Pharmacotherapy Specialist Infectious Diseases
  NYU Langone Health
  New york city, New York, United States